Skip to main content
. 2023 Mar 22;62(5):2105–2113. doi: 10.1007/s00394-023-03134-8

Table 2.

Adjusted mean levels (95% confidence interval) of inflammatory markers according to frequency of avocado consumption, Multi-Ethnic Study of Atherosclerosis (Exam 1), United States

Inflammatory markerb Avocado/guacamole consumptiona p for trend
Rare or never Medium Heavy
C-reactive protein (mg/L)
 Model 1c 1.80 (1.73–1.87) 1.79 (1.64–1.96) 1.65 (1.49–1.84) 0.19
 Model 2d 2.48 (2.31–2.67) 2.51 (2.26–2.79) 2.47 (2.19–2.77) 0.97
 Model 3e 2.52 (2.36–2.69) 2.50 (2.26–2.77) 2.54 (2.27–2.83) 0.94
Interleukin-2 (pg/mL)
 Model 1c 957.62 (940.12–975.44) 937.40 (897.01–979.61) 950.87 (904.49–999.63) 0.59
 Model 2d 999.24 (964.29–1035.47) 979.09 (928.16–1032.82) 992.76 (935.49–1052.54) 0.62
 Model 3e 997.03 (964.35–1030.93) 968.76 (920.92–1019.10) 997.03 (943.16–1053.98) 0.65
Interleukin-6 (pg/mL)
 Model 1c 1.24 (1.21–1.27) 1.21 (1.14–1.27) 1.23 (1.16–1.31) 0.68
 Model 2d 1.57 (1.50–1.63) 1.54 (1.45–1.64) 1.62 (1.51–1.74) 0.52
 Model 3e 1.57 (1.52–1.64) 1.53 (1.44–1.62) 1.62 (1.52–1.72) 0.73
Total homocysteine (umol/L)
 Model 1c 9.03 (8.94–9.12) 8.85 (8.65–9.06) 9.09 (8.85–9.34) 0.90
 Model 2d 9.19 (9.02–9.37) 9.05 (8.80–9.30) 9.32 (9.03–9.61) 0.74
 Model 3e 9.18 (9.01–9.35) 9.06 (8.81–9.31) 9.33 (9.05–9.63) 0.52
Fibrinogen (mg/dL)
 Model 1c 340.16 (337.71–342.63) 336.87 (331.39–342.44) 334.31 (328.01–340.74) 0.06
 Model 2d 357.99 (353.28–362.76) 355.83 (348.92–362.87) 354.23 (346.54–362.09) 0.25
 Model 3e 358.62 (354.16–363.14) 355.19 (348.56–361.95) 353.91 (346.58–361.40) 0.11
Tumor necrosis factor-A soluble receptors (pg/mL)
 Model 1c 1366.21 (1348.62–1384.03) 1347.97 (1306.79–1390.45) 1324.76 (1278.97–1372.19) 0.09
 Model 2d 1465.82 (1430.73–1501.77) 1440.80 (1389.07–1494.45) 1426.53 (1369.70–1485.71) 0.10
 Model 3e 1468.95 (1436.59–1502.04) 1457.09 (1408.27–1507.60) 1452.16 (1399.20–1507.13) 0.45

aRare or never = daily serving size ≤ 0.03; Medium = 0.03 < daily serving size < 0.1; Heavy = 0.1 ≤ daily serving size

bAntilogs of adjusted mean levels of log-transformed inflammatory markers

cModel 1 adjusted for age, sex, race/ethnicity, field center, educational level, income, energy intake (kcals/day). Sample sizes for each inflammatory markers varied because of missing covariates: C-reactive protein (n = 5336); Interleukin-2 (n = 2304); Interleukin-6 (n = 5240); Total homocysteine (n = 5354); Fibrinogen (n = 5337); Tumor Necrosis Factor-A Soluble Receptors (n = 2309)

dModel 2 further adjusted for smoking status, alcohol consumption, physical activity, diet quality (AHEI), BMI, Exam 1 Diabetes Type, medication(s) that may influence inflammatory markers. Sample sizes for each inflammatory markers varied because of missing covariates: C-reactive protein (n = 5115); Interleukin-2 (n = 2220); Interleukin-6 (n = 5025); Total homocysteine (n = 5132); Fibrinogen (n = 5116); Tumor Necrosis Factor-A Soluble Receptors (n = 2226)

eModel 3 adjusted for covariates selected from the stepwise selection procedure (significance level of 0.05 was used as a criterion for variables to enter or stay in the model). C-reactive protein—adjusted for age, sex, race/ethnicity, smoking status, AHEI, BMI, Exam 1 Diabetes Type. Interleukin-2—adjusted for age, sex, race/ethnicity, income, smoking status, alcohol consumption, BMI, Exam 1 Diabetes Type. Interleukin-6—adjusted for age, sex, race/ethnicity, income, smoking status, physical activity, BMI, Exam 1 Diabetes Type. Total homocysteine: age, sex, race/ethnicity, field center, income, smoking status, alcohol consumption, AHEI, BMI, Exam 1 Diabetes Type. Fibrinogen—adjusted for age, sex, race/ethnicity, field center, income, smoking status, alcohol consumption, physical activity, BMI, Exam 1 Diabetes Type. Tumor Necrosis Factor-A Soluble Receptors—adjusted for age, sex, race/ethnicity, smoking status, alcohol consumption, BMI, Exam 1 Diabetes Type